Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$57.18 -1.26 (-2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Change in Accured Expenses (2009 - 2026)

Updated

Biomarin Pharmaceutical (BMRN) posted Change in Accured Expenses of $23.17 million for Q2 2026, up 301.8% from $5.77 million a year earlier and up 647.3% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Change in Accured Expenses (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Biomarin Pharmaceutical was $89.29 million, up 255.3% year-over-year; for FY2025, it came in at $66.14 million.

  • In prior years, Biomarin Pharmaceutical's Change in Accured Expenses was -$32.24 million in FY2024, $68.85 million in FY2023 (+16.7%), $59.02 million in FY2022 (+276.2%) and $15.69 million in FY2021.
  • Quarterly Change in Accured Expenses has run from a low of -$100.26 million in Q4 2024 to a high of $122.28 million in Q3 2024 over five years.
  • On a year-over-year basis, Change in Accured Expenses increased in three of the last four quarters, with growth averaging 92.2%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q2 2026, with growth of 301.8%; the weakest was Q2 2022, with a decline of 84.3%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was $3.1 million (Q1 2026), -$53.34 million (Q4 2025) and $116.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Biomarin Pharmaceutical 11.07 Bn 4.93 Bn 786.91 Mn 23.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.17 Mn
Mar 31, 2026 3.10 Mn
Dec 31, 2025 -53.34 Mn
Sep 30, 2025 116.37 Mn
Jun 30, 2025 5.77 Mn
Mar 31, 2025 -2.66 Mn
Dec 31, 2024 -100.26 Mn
Sep 30, 2024 122.28 Mn
Jun 30, 2024 4.75 Mn
Mar 31, 2024 -59.01 Mn
Dec 31, 2023 12.52 Mn
Sep 30, 2023 81.43 Mn
Jun 30, 2023 6.59 Mn
Mar 31, 2023 -31.69 Mn
Dec 31, 2022 61.42 Mn
Sep 30, 2022 73.95 Mn
Jun 30, 2022 1.80 Mn
Mar 31, 2022 -78.14 Mn
Dec 31, 2021 22.82 Mn
Sep 30, 2021 53.76 Mn
API Access

Biomarin Pharmaceutical Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BMRN&period=max&api_key=YOUR_API_KEY